Dynamic Monitoring of Circulating Tumor <scp>DNA</scp> to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort Study
In glioma patients undergoing primary surgery, dynamic monitoring of ctDNA and genotyping can be used for early risk stratification, efficacy monitoring, and early recurrence detection, and provide a basis for clinical research to evaluate early therapeutic intervention.
Authors
- Xingyao Bu (ORCID: https://orcid.org/0000-0002-2179-9742)
- Yage Bu
- Zhao Ruijiao
- Yushuai Gao
- Jiubing Zhang (ORCID: https://orcid.org/0009-0000-2549-4068)
- Sensen Xu (ORCID: https://orcid.org/0000-0003-4290-9514)
- Shuang Wu (ORCID: https://orcid.org/0000-0001-5418-6902)
- Kaiyuan Deng (ORCID: https://orcid.org/0000-0001-6525-6363)
- Guangzhong Guo (ORCID: https://orcid.org/0009-0003-2340-5393)
- Zhiyuan Sheng (ORCID: https://orcid.org/0000-0002-0924-9940)
- Ziyue Zhang (ORCID: https://orcid.org/0000-0002-6050-779X)
- Tianxiao Li (ORCID: https://orcid.org/0000-0003-3585-5001)
- Meiyun Wang
- Zhaoyue Yan
- Dayang Wang
- Jinliang Yu (ORCID: https://orcid.org/0000-0003-2486-659X)
Institutions
- Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/cam4.70733
- Citations
- 2
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- Natural Science Foundation of Henan Province